サマリー

市場の分析と洞察。抗うつ剤の世界市場
COVID-19の流行により、抗うつ剤の世界市場規模は2022年に1億4890万米ドルと推定され、2028年には年平均成長率3.3％で1億8000万米ドルに再調整されると予測されています。この健康危機による経済変化を十分に考慮し、2021年に抗うつ剤世界市場の％を占めた三環系抗うつ剤は、2028年までに百万米ドルの価値を持ち、COVID-19以降の期間に修正された％のCAGRで成長すると予測されます。一方、病院部門は、この予測期間を通して％CAGRに変更されています。

2021年の中国の抗うつ剤市場規模は百万米ドル、米国と欧州の抗うつ剤はそれぞれ百万米ドル、百万米ドルとされています。2021年の米国の割合は％、中国と欧州はそれぞれ％、％で、中国の割合は2028年には％に達すると予測され、分析期間を通じてCAGRは％であることがわかりました。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。ヨーロッパの抗うつ剤市場については、ドイツは2028年までに100万ドルに達すると予測され、予測期間中のCAGRは%となっています。
抗うつ剤の世界的な主要メーカーは、H Lundbeck、Astrazeneca、Eli Lilly and Company、Sun Pharmaceuticals、Pfizer Inc、GlaxoSmithKline、Bristol-Myers Squibb Company、Johnson & Johnson、Merckなどです。2021年、世界の上位5社は売上高で約 %のシェアを占めています。

世界の抗うつ剤の範囲とセグメント
抗うつ剤市場は、タイプ別と用途別に分類されます。世界の抗うつ剤市場におけるプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして利用することで、優位に立つことができるようになります。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の売上、収益、予測に焦点を当てています。

タイプ別セグメント
三環系抗うつ薬
選択的セロトニン再取り込み阻害薬
選択的ノルエピネフリン再取込阻害薬
モノアミン酸化酵素阻害剤
ベンゾジアゼピン系
抗精神病薬
新薬
用途別セグメント
病院
クリニック
その他

会社別
Hルンドベック
アストラゼネカ
イーライリリー・アンド・カンパニー
サンファーマシューティカルズ
ファイザー株式会社
グラクソ・スミスクライン
ブリストル・マイヤーズ スクイブ社
ジョンソン・エンド・ジョンソン
メルク
サノフィ

地域別
北米
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
アジア太平洋地域
中国
日本
韓国
インド
オーストラリア
台湾
インドネシア
タイ
マレーシア
フィリピン
ベトナム
中南米
メキシコ
ブラジル
アルゼンチン
中東・アフリカ
トルコ
サウジアラビア
UAE

ページTOPに戻る

目次

1 Study Coverage
1.1 Antidepressants Product Introduction
1.2 Market by Type
1.2.1 Global Antidepressants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Tricyclic Antidepressants
1.2.3 Selective Serotonin Reuptake Inhibitors
1.2.4 Selective Norepinephrine Reuptake Inhibitors
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Benzodiazepines
1.2.7 Antipsychotics
1.2.8 Novel Agents
1.3 Market by Application
1.3.1 Global Antidepressants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antidepressants Sales Estimates and Forecasts 2017-2028
2.2 Global Antidepressants Revenue Estimates and Forecasts 2017-2028
2.3 Global Antidepressants Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antidepressants Sales by Region
2.4.1 Global Antidepressants Sales by Region (2017-2022)
2.4.2 Global Sales Antidepressants by Region (2023-2028)
2.5 Global Antidepressants Revenue by Region
2.5.1 Global Antidepressants Revenue by Region (2017-2022)
2.5.2 Global Antidepressants Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antidepressants Sales by Manufacturers
3.1.1 Global Top Antidepressants Manufacturers by Sales (2017-2022)
3.1.2 Global Antidepressants Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antidepressants in 2021
3.2 Global Antidepressants Revenue by Manufacturers
3.2.1 Global Antidepressants Revenue by Manufacturers (2017-2022)
3.2.2 Global Antidepressants Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antidepressants Revenue in 2021
3.3 Global Antidepressants Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antidepressants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antidepressants Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antidepressants Sales by Type
4.1.1 Global Antidepressants Historical Sales by Type (2017-2022)
4.1.2 Global Antidepressants Forecasted Sales by Type (2023-2028)
4.1.3 Global Antidepressants Sales Market Share by Type (2017-2028)
4.2 Global Antidepressants Revenue by Type
4.2.1 Global Antidepressants Historical Revenue by Type (2017-2022)
4.2.2 Global Antidepressants Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antidepressants Revenue Market Share by Type (2017-2028)
4.3 Global Antidepressants Price by Type
4.3.1 Global Antidepressants Price by Type (2017-2022)
4.3.2 Global Antidepressants Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antidepressants Sales by Application
5.1.1 Global Antidepressants Historical Sales by Application (2017-2022)
5.1.2 Global Antidepressants Forecasted Sales by Application (2023-2028)
5.1.3 Global Antidepressants Sales Market Share by Application (2017-2028)
5.2 Global Antidepressants Revenue by Application
5.2.1 Global Antidepressants Historical Revenue by Application (2017-2022)
5.2.2 Global Antidepressants Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antidepressants Revenue Market Share by Application (2017-2028)
5.3 Global Antidepressants Price by Application
5.3.1 Global Antidepressants Price by Application (2017-2022)
5.3.2 Global Antidepressants Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antidepressants Market Size by Type
6.1.1 North America Antidepressants Sales by Type (2017-2028)
6.1.2 North America Antidepressants Revenue by Type (2017-2028)
6.2 North America Antidepressants Market Size by Application
6.2.1 North America Antidepressants Sales by Application (2017-2028)
6.2.2 North America Antidepressants Revenue by Application (2017-2028)
6.3 North America Antidepressants Market Size by Country
6.3.1 North America Antidepressants Sales by Country (2017-2028)
6.3.2 North America Antidepressants Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Antidepressants Market Size by Type
7.1.1 Europe Antidepressants Sales by Type (2017-2028)
7.1.2 Europe Antidepressants Revenue by Type (2017-2028)
7.2 Europe Antidepressants Market Size by Application
7.2.1 Europe Antidepressants Sales by Application (2017-2028)
7.2.2 Europe Antidepressants Revenue by Application (2017-2028)
7.3 Europe Antidepressants Market Size by Country
7.3.1 Europe Antidepressants Sales by Country (2017-2028)
7.3.2 Europe Antidepressants Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antidepressants Market Size by Type
8.1.1 Asia Pacific Antidepressants Sales by Type (2017-2028)
8.1.2 Asia Pacific Antidepressants Revenue by Type (2017-2028)
8.2 Asia Pacific Antidepressants Market Size by Application
8.2.1 Asia Pacific Antidepressants Sales by Application (2017-2028)
8.2.2 Asia Pacific Antidepressants Revenue by Application (2017-2028)
8.3 Asia Pacific Antidepressants Market Size by Region
8.3.1 Asia Pacific Antidepressants Sales by Region (2017-2028)
8.3.2 Asia Pacific Antidepressants Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Antidepressants Market Size by Type
9.1.1 Latin America Antidepressants Sales by Type (2017-2028)
9.1.2 Latin America Antidepressants Revenue by Type (2017-2028)
9.2 Latin America Antidepressants Market Size by Application
9.2.1 Latin America Antidepressants Sales by Application (2017-2028)
9.2.2 Latin America Antidepressants Revenue by Application (2017-2028)
9.3 Latin America Antidepressants Market Size by Country
9.3.1 Latin America Antidepressants Sales by Country (2017-2028)
9.3.2 Latin America Antidepressants Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Antidepressants Market Size by Type
10.1.1 Middle East and Africa Antidepressants Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antidepressants Revenue by Type (2017-2028)
10.2 Middle East and Africa Antidepressants Market Size by Application
10.2.1 Middle East and Africa Antidepressants Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antidepressants Revenue by Application (2017-2028)
10.3 Middle East and Africa Antidepressants Market Size by Country
10.3.1 Middle East and Africa Antidepressants Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antidepressants Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 H Lundbeck
11.1.1 H Lundbeck Corporation Information
11.1.2 H Lundbeck Overview
11.1.3 H Lundbeck Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 H Lundbeck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 H Lundbeck Recent Developments
11.2 Astrazeneca
11.2.1 Astrazeneca Corporation Information
11.2.2 Astrazeneca Overview
11.2.3 Astrazeneca Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Astrazeneca Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Astrazeneca Recent Developments
11.3 Eli Lilly and Company
11.3.1 Eli Lilly and Company Corporation Information
11.3.2 Eli Lilly and Company Overview
11.3.3 Eli Lilly and Company Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Eli Lilly and Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Eli Lilly and Company Recent Developments
11.4 Sun Pharmaceuticals
11.4.1 Sun Pharmaceuticals Corporation Information
11.4.2 Sun Pharmaceuticals Overview
11.4.3 Sun Pharmaceuticals Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Sun Pharmaceuticals Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Sun Pharmaceuticals Recent Developments
11.5 Pfizer Inc.
11.5.1 Pfizer Inc. Corporation Information
11.5.2 Pfizer Inc. Overview
11.5.3 Pfizer Inc. Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Pfizer Inc. Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Inc. Recent Developments
11.6 GlaxoSmithKline
11.6.1 GlaxoSmithKline Corporation Information
11.6.2 GlaxoSmithKline Overview
11.6.3 GlaxoSmithKline Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 GlaxoSmithKline Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 GlaxoSmithKline Recent Developments
11.7 Bristol-Myers Squibb Company
11.7.1 Bristol-Myers Squibb Company Corporation Information
11.7.2 Bristol-Myers Squibb Company Overview
11.7.3 Bristol-Myers Squibb Company Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Bristol-Myers Squibb Company Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Bristol-Myers Squibb Company Recent Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Corporation Information
11.8.2 Johnson & Johnson Overview
11.8.3 Johnson & Johnson Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Johnson & Johnson Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Johnson & Johnson Recent Developments
11.9 Merck
11.9.1 Merck Corporation Information
11.9.2 Merck Overview
11.9.3 Merck Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Merck Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Merck Recent Developments
11.10 Sanofi
11.10.1 Sanofi Corporation Information
11.10.2 Sanofi Overview
11.10.3 Sanofi Antidepressants Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Sanofi Antidepressants Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Sanofi Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antidepressants Industry Chain Analysis
12.2 Antidepressants Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antidepressants Production Mode & Process
12.4 Antidepressants Sales and Marketing
12.4.1 Antidepressants Sales Channels
12.4.2 Antidepressants Distributors
12.5 Antidepressants Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antidepressants Industry Trends
13.2 Antidepressants Market Drivers
13.3 Antidepressants Market Challenges
13.4 Antidepressants Market Restraints
14 Key Findings in The Global Antidepressants Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer